CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 500 of 529 entries

View as:

Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E

Phase: N/A Priority: Normal

NCT ID: NCT01792115 Org: User:

Start: 05/01/13 End: 08/30/19 Due: 08/30/20

Drug Therapy in Lupus Nephropathy

Phase: N/A Priority: Normal

NCT ID: NCT00001212 Org: User:

Start: 11/30/86 End: 09/30/04 Due: 09/30/05

History of Hepatitis C in Volunteer Blood Donors

Phase: N/A Priority: Normal

NCT ID: NCT00001982 Org: User:

Start: 06/30/93 End: 04/30/00 Due: 04/30/01

Genetic Studies of Insulin and Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00001987 Org: User:

Start: 02/01/76 End: - Due: -

Lamivudine for Chronic Hepatitis B

Phase: N/A Priority: Normal

NCT ID: NCT00001457 Org: User:

Start: 09/30/95 End: 09/30/05 Due: 09/30/06

The Modification of Diet in Renal Disease Study

Phase: N/A Priority: Normal

NCT ID: NCT04364113 Org: User:

Start: 01/01/89 End: 12/31/00 Due: 12/31/01

Kidney Transplant for HIV-Infected Patients in Renal Failure

Phase: N/A Priority: Normal

NCT ID: NCT00009009 Org: User:

Start: 01/31/01 End: 12/31/02 Due: 12/31/03

Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal

NCT ID: NCT00505375 Org: User:

Start: 02/29/08 End: 05/31/12 Due: 05/31/13

VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

Phase: N/A Priority: Normal

NCT ID: NCT06092333 Org: User:

Start: 01/31/25 End: 08/31/28 Due: 08/31/29

Quitting Caffeine for Better Glucose Metabolism

Phase: N/A Priority: Normal

NCT ID: NCT01030796 Org: User:

Start: 12/31/09 End: 04/30/10 Due: 04/30/11

Screening for Barrett's Esophagus in Otolaryngology Patients

Phase: N/A Priority: Normal

NCT ID: NCT00695227 Org: User:

Start: 05/31/04 End: 12/31/11 Due: 12/31/12

Oxidative Stress and Vitamin E Requirements

Phase: N/A Priority: Normal

NCT ID: NCT00067899 Org: User:

Start: 09/30/00 End: 12/31/05 Due: 12/31/06

Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression

Phase: N/A Priority: Normal

NCT ID: NCT00021788 Org: User:

Start: 07/31/00 End: 12/31/01 Due: 12/31/02

Impact of Non-Commercialism Policy in Seattle Schools

Phase: N/A Priority: Normal

NCT ID: NCT00063700 Org: User:

Start: 09/30/02 End: 07/31/05 Due: 07/31/06

Diabetes Control and Complications Trial (DCCT)

Phase: N/A Priority: Normal

NCT ID: NCT00360815 Org: User:

Start: 08/31/83 End: 04/30/93 Due: 04/30/94

Obesity Assessment and Education Through the Internet

Phase: N/A Priority: Normal

NCT ID: NCT00149682 Org: User:

Start: 07/31/05 End: 12/31/07 Due: 12/31/08

Program to Reduce Incontinence by Diet and Exercise

Phase: N/A Priority: Normal

NCT ID: NCT00091988 Org: User:

Start: 07/31/04 End: 11/30/07 Due: 11/30/08

Assessment of Beta Cell Mass by PET Scans With [11C] Dihydrotetrabenazine (DTBZ) in Longstanding Type 1 Diabetes.

Phase: N/A Priority: Normal

NCT ID: NCT00738907 Org: User:

Start: 11/30/06 End: 05/31/08 Due: 05/31/09

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

Phase: N/A Priority: Normal

NCT ID: NCT00001191 Org: User:

Start: 02/03/83 End: 12/10/07 Due: 12/10/08

Clinical Approaches to Ileal Pouch Dysfunction

Phase: N/A Priority: Normal

NCT ID: NCT00293553 Org: User:

Start: - End: 12/31/07 Due: 12/31/08

Preventing Depression Recurrence in Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00374426 Org: User:

Start: 03/31/98 End: 10/31/04 Due: 10/31/05

A Pilot Study of Diabetes Risk Reduction Program With WIC Mothers(The Special Supplemental Nutrition Program for Women, Infants, and Children) Overweight WIC Mothers

Phase: N/A Priority: Normal

NCT ID: NCT00944060 Org: User:

Start: - End: - Due: -

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Phase: N/A Priority: Normal

NCT ID: NCT05832229 Org: User:

Start: 12/07/23 End: 11/30/28 Due: 11/30/29

Assessment of Sympathetic Nervous System Activity by Microneurography Recording Technique

Phase: N/A Priority: Normal

NCT ID: NCT00341770 Org: User:

Start: 04/12/91 End: 11/23/10 Due: 11/23/11

ORWH:SCOR - Sex/Gender Factors Affecting Women's Health

Phase: N/A Priority: Normal

NCT ID: NCT00068120 Org: User:

Start: - End: - Due: -

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E	NCT01792115	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2013-05-01	2019-08-30	2020-08-30	-	-	2025-07-14
Drug Therapy in Lupus Nephropathy	NCT00001212	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	1986-11-30	2004-09-30	2005-09-30	-	-	2025-07-14
History of Hepatitis C in Volunteer Blood Donors	NCT00001982	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	1993-06-30	2000-04-30	2001-04-30	-	-	2025-07-14
Genetic Studies of Insulin and Diabetes	NCT00001987	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	1976-02-01	-	-	-	-	2025-07-14
Lamivudine for Chronic Hepatitis B	NCT00001457	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	1995-09-30	2005-09-30	2006-09-30	-	-	2025-07-14
The Modification of Diet in Renal Disease Study	NCT04364113	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	1989-01-01	2000-12-31	2001-12-31	-	-	2025-07-14
Kidney Transplant for HIV-Infected Patients in Renal Failure	NCT00009009	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2001-01-31	2002-12-31	2003-12-31	-	-	2025-07-14
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus	NCT00505375	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2008-02-29	2012-05-31	2013-05-31	-	-	2025-07-14
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B	NCT06092333	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2025-01-31	2028-08-31	2029-08-31	-	-	2025-07-14
Quitting Caffeine for Better Glucose Metabolism	NCT01030796	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2009-12-31	2010-04-30	2011-04-30	-	-	2025-07-14
Screening for Barrett's Esophagus in Otolaryngology Patients	NCT00695227	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2004-05-31	2011-12-31	2012-12-31	-	-	2025-07-14
Oxidative Stress and Vitamin E Requirements	NCT00067899	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2000-09-30	2005-12-31	2006-12-31	-	-	2025-07-14
Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression	NCT00021788	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2000-07-31	2001-12-31	2002-12-31	-	-	2025-07-14
Impact of Non-Commercialism Policy in Seattle Schools	NCT00063700	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2002-09-30	2005-07-31	2006-07-31	-	-	2025-07-14
Diabetes Control and Complications Trial (DCCT)	NCT00360815	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	1983-08-31	1993-04-30	1994-04-30	-	-	2025-07-14
Obesity Assessment and Education Through the Internet	NCT00149682	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2005-07-31	2007-12-31	2008-12-31	-	-	2025-07-14
Program to Reduce Incontinence by Diet and Exercise	NCT00091988	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2004-07-31	2007-11-30	2008-11-30	-	-	2025-07-14
Assessment of Beta Cell Mass by PET Scans With [11C] Dihydrotetrabenazine (DTBZ) in Longstanding Type 1 Diabetes.	NCT00738907	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2006-11-30	2008-05-31	2009-05-31	-	-	2025-07-14
The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid	NCT00001191	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	1983-02-03	2007-12-10	2008-12-10	-	-	2025-07-14
Clinical Approaches to Ileal Pouch Dysfunction	NCT00293553	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	-	2007-12-31	2008-12-31	-	-	2025-07-14
Preventing Depression Recurrence in Diabetes	NCT00374426	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	1998-03-31	2004-10-31	2005-10-31	-	-	2025-07-14
A Pilot Study of Diabetes Risk Reduction Program With WIC Mothers(The Special Supplemental Nutrition Program for Women, Infants, and Children) Overweight WIC Mothers	NCT00944060	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	-	-	-	-	-	2025-07-14
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States	NCT05832229	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	2023-12-07	2028-11-30	2029-11-30	-	-	2025-07-14
Assessment of Sympathetic Nervous System Activity by Microneurography Recording Technique	NCT00341770	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	1991-04-12	2010-11-23	2011-11-23	-	-	2025-07-14
ORWH:SCOR - Sex/Gender Factors Affecting Women's Health	NCT00068120	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	user2@example.com	None	-	-	-	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance